THE DEVELOPMENT OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELS TO DETERMINE THE OPTIMAL SAFE AND AP…
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- 75F40123P00404
- Contractor
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- Food and Drug Administration
- Award amount
- $99,975
- Period of performance
- Sep 18, 2023 – Sep 24, 2024
- NAICS
- 541990 — All Other Professional, Scientific, and Technical Services
- PSC
- PSC AN11
- Place of performance
- MD
Public award description
THE DEVELOPMENT OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELS TO DETERMINE THE OPTIMAL SAFE AND APPROPRIATE DOSE OF ONCOLOGY DRUGS FOR PREGNANT WOMEN WITH CANCER.
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.